Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial - The Lancet Respiratory Medicine
Flowchart of screening for randomized clinical trials and for run-in... | Download Scientific Diagram
PDF) Randomized clinical trials with run-in periods: frequency, characteristics and reporting
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Analysis of clinical trial registry entry histories using the novel R package cthist | PLOS ONE
Run in phases for clinical trials: everything you need to know in 2min - YouTube
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Clinical Trials in the European Union - EMA
NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies | National Institute on Aging
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial | Nature Communications
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer | Nature Communications
Run-in bias in randomised trials: the case of COPD medications | European Respiratory Society
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial - The Lancet
Early Phase Clinical Trial Solutions - CMIC | Pharmaceutical Development Services (CRO, CDMO, CSO, Healthcare, Japan Entry)
COVID-19 impact: rethinking how to plan for and run clinical trials – AXXELIS
In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials | Nature Communications
study design. Notes: Throughout the run-in phase, all patients received... | Download Scientific Diagram
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Clinical Trials in the European Union - EMA
CTIS for sponsors - EMA
